- Home
- BHAT vs SILO Comparison
BHAT vs SILO Comparison
Compare BHAT & SILO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHAT
- SILO
- Stock Information
- Founded
- BHAT 2010
- SILO 2010
- Country
- BHAT China
- SILO United States
- Employees
- BHAT N/A
- SILO N/A
- Industry
- BHAT Recreational Games/Products/Toys
- SILO Apparel
- Sector
- BHAT Consumer Discretionary
- SILO Consumer Discretionary
- Exchange
- BHAT Nasdaq
- SILO Nasdaq
- Market Cap
- BHAT 12.3M
- SILO 5.9M
- IPO Year
- BHAT 2019
- SILO N/A
- Fundamental
- Price
- BHAT $1.75
- SILO $0.81
- Analyst Decision
- BHAT
- SILO
- Analyst Count
- BHAT 0
- SILO 0
- Target Price
- BHAT N/A
- SILO N/A
- AVG Volume (30 Days)
- BHAT 1.0M
- SILO 337.6K
- Earning Date
- BHAT 04-30-2025
- SILO 11-11-2025
- Dividend Yield
- BHAT N/A
- SILO N/A
- EPS Growth
- BHAT N/A
- SILO N/A
- EPS
- BHAT N/A
- SILO N/A
- Revenue
- BHAT $18,724,190.00
- SILO $72,102.00
- Revenue This Year
- BHAT N/A
- SILO $1.86
- Revenue Next Year
- BHAT N/A
- SILO N/A
- P/E Ratio
- BHAT N/A
- SILO N/A
- Revenue Growth
- BHAT N/A
- SILO N/A
- 52 Week Low
- BHAT $1.51
- SILO $0.41
- 52 Week High
- BHAT $45.00
- SILO $3.37
- Technical
- Relative Strength Index (RSI)
- BHAT 53.14
- SILO 67.54
- Support Level
- BHAT $1.62
- SILO $0.58
- Resistance Level
- BHAT $2.02
- SILO $0.70
- Average True Range (ATR)
- BHAT 0.17
- SILO 0.04
- MACD
- BHAT 0.01
- SILO 0.01
- Stochastic Oscillator
- BHAT 47.06
- SILO 91.94
About BHAT Blue Hat Interactive Entertainment Technology
Blue Hat Interactive Entertainment Technology is focused on commodity trading, including chemicals, jewelry, and precious metals such as gold. It operates a gold and diamond trading and supply chain business. Its business model encompasses physical gold trading, diamond trading, gold derivatives trading, and the development of AI-enabled trading platforms. Its segments include Diamond trading, Commodity trading, Information service, Interactive toys - animation series, and Interactive toys - game series. It derives revenue from Diamond trading. The majority of its revenues are generated in PRC.
About SILO Silo Pharma Inc.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.